Atalay Atakan, Gocen Ugur
Department of Cardiovascular Surgery, University of Cukurova Medical Faculty, Adana, Turkey.
Heart Surg Forum. 2017 Feb 28;20(1):E015-E018. doi: 10.1532/hsf.1640.
The arterial switch operation (ASO) has become the surgical approach of choice for transposition of the great arteries. The aim of this paper was to describe the outcomes in patients who underwent arterial switch operation and to analyze the predictors of in-hospital mortality and further need for reoperation at a single-center institution. We reviewed our 9-year experience with arterial switch operation (ASO) for transposition of the great arteries (TGA) or Taussig-Bing anomaly (TBA) to assess the early and midterm outcomes.
Between January 2007 and May 2016, 34 consecutive patients who underwent ASO for TGA with IVS; and TGA with ventricular septal defect (VSD); and double outlet right ventricle (DORV) with subpulmonary VSD at our institution were included in this retrospective study. The same surgeons operated on all patients. Patients' charts, surgical reports, and echocardiograms were retrospectively reviewed. Median follow-up time ranged from 1 to 9 years, 54.2 (0.4-108) months.
There were 2 (5%) in-hospital deaths. Late death occurred in 1 (2.9%) of 32 survivors. One patient (2.9%) required reintervention. The freedom from reintervention rate was 95.9 ± 1.8% at 9 years. Two patients (3.9%) developed moderate neoaortic regurgitation during the follow-up and one patient underwent reoperation mainly for neopulmonary artery stenosis. The analysis showed that weight, cross-clamp (CC) time, cardiopulmonary bypass (CPB) time, and age of operation are strong predictors for mortality.
ASO remains the procedure of choice for the treatment of various forms of TGA with acceptable early and midterm outcome, and can also be performed with a low risk of early mortality and satisfactory midterm outcomes even in a small-volume center. Early and midterm survival is excellent after arterial switch operation.
动脉调转术(ASO)已成为大动脉转位的首选手术方式。本文旨在描述接受动脉调转术患者的预后情况,并分析单中心机构中住院死亡率及再次手术需求的预测因素。我们回顾了9年中对大动脉转位(TGA)或陶西格-宾畸形(TBA)进行动脉调转术(ASO)的经验,以评估早期和中期预后。
在2007年1月至2016年5月期间,本回顾性研究纳入了34例在我院接受ASO治疗的患者,包括合并室间隔完整(IVS)的TGA、合并室间隔缺损(VSD)的TGA以及合并肺动脉下VSD的右心室双出口(DORV)。所有患者均由同一组外科医生进行手术。对患者病历、手术报告和超声心动图进行回顾性分析。中位随访时间为1至9年,即54.2(0.4 - 108)个月。
有2例(5%)患者在住院期间死亡。32例幸存者中有1例(2.9%)发生晚期死亡。1例患者(2.9%)需要再次干预。9年时无需再次干预的比例为95.9 ± 1.8%。2例患者(3.9%)在随访期间出现中度新主动脉瓣反流,1例患者主要因新肺动脉狭窄接受了再次手术。分析表明,体重、主动脉阻断(CC)时间、体外循环(CPB)时间和手术年龄是死亡率的有力预测因素。
ASO仍然是治疗各种类型TGA的首选手术方式,早期和中期预后可接受,即使在小容量中心进行,早期死亡率风险也较低,中期预后令人满意。动脉调转术后早期和中期生存率良好。